| PMC full text: | Curr Opin Immunol. Author manuscript; available in PMC 2012 Sep 27. Published in final edited form as: Curr Opin Immunol. 2009 Apr; 21(2): 233–240. Published online 2009 Mar 21. doi: 10.1016/j.coi.2009.03.002 |
Figure 3
Survival of patients treated with cell transfer therapy in four consecutive clinical trials using increasing regimens of a lymphodepleting preparative regimen prior to adoptive cell transfer (NMA, non-myeloablative chemotherapy; TBI, total body irradiation). The number in parentheses is the number of patients in each trial.
